Protein & Peptide Letters
Title:Letter to the Editor: The Versatility of Tumor Suppressor Proteins and its Therapeutic Potential
Volume: 24 Issue: 8
Author(s): Razvan T. Radulescu*
Affiliation:
- Molecular Concepts Research (MCR), Münster/Westfalen,Germany
Export Options
About this article
Cite this article as:
Radulescu T. Razvan *, Letter to the Editor: The Versatility of Tumor Suppressor Proteins and its Therapeutic Potential, Protein & Peptide Letters 2017; 24 (8) . https://dx.doi.org/10.2174/0929866524666170830124707
DOI https://dx.doi.org/10.2174/0929866524666170830124707 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Measles Virus Induced Immunosuppression: Targets and Effector Mechanisms
Current Molecular Medicine Phosphoprotein Phosphatase 1 Complexes in Spermatogenesis
Current Molecular Pharmacology Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease
Current Medicinal Chemistry Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma
Current Cancer Drug Targets Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Retraction Note: Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer
Current Pharmaceutical Biotechnology Molecular Studies on Novel Antitumor Bis 1,4-Dihydropyridine Derivatives Against Lung Carcinoma and their Limited Side Effects on Normal Melanocytes
Anti-Cancer Agents in Medicinal Chemistry Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy
Current Medicinal Chemistry Nonviral Vectors for Cancer Gene Therapy: Prospects for Integrating Vectors and Combination Therapies
Current Gene Therapy Nutlins and Ionizing Radiation in Cancer Therapy
Current Pharmaceutical Design Complex Effect of Adenovirus Early Region Proteins on Innate Immune System
Inflammation & Allergy - Drug Targets (Discontinued) The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers
Current Medicinal Chemistry Stem Cell Fate Decisions: The Role of Heparan Sulfate in the Control of Autocrine and Paracrine Signals
Current Stem Cell Research & Therapy Target Driven Preclinical Screening for New Antimitotic Chemotherapy Agents
Current Topics in Medicinal Chemistry SENP1 as A Biomarker for the Diagnosis of Cancer: Review of the Science and Published Patents
Recent Patents on Biomarkers Preclinical Studies of PROTACs in Hematological Malignancies
Cardiovascular & Hematological Disorders-Drug Targets Genitourinary Tract Tumors in Children: An Update
Current Pediatric Reviews Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry DNA Damage Response Pathways and Cell Cycle Checkpoints in Colorectal Cancer: Current Concepts and Future Perspectives for Targeted Treatment
Current Cancer Drug Targets Stability of Genomic Imprinting in Embryonic Stem Cells: Lessons from Assisted Reproductive Technology
Current Stem Cell Research & Therapy